(11E,13E)-icosa-11,13-dienoic acid

• 分子结构分类: 有机化合物 - 脂质和类脂质分子 - 脂肪酰基
• 英文名称: (11E,13E)-icosa-11,13-dienoic acid
• 化学式: C₂₀H₃₆O₂
• 分子量: 308.5
• InChiKey: UNFHLCKMPAPDAZ-XBLVEGMJSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  7.2
• 重原子数：
  22
• 可旋转键数：
  16
• 环数：
  0.0
• sp3杂化的碳原子比例：
  0.75
• 拓扑面积：
  37.3
• 氢给体数：
  1
• 氢受体数：
  2

文献信息

• METHOD FOR CONTROLLING BODY FAT AND/OR BODY WEIGHT IN ANIMALS AND PHARMACEUTICAL COMPOSITIONS FOR USE THEREIN
  申请人：WISCONSIN ALUMNI RESEARCH FOUNDATION

  公开号：EP0942717A2

  公开（公告）日：1999-09-22
• Resin and Paint Coating Compositions Comprising Highly Esterified Polyol Polyesters with One Pair of Conjugated Double Bonds
  申请人：Eslinger Delano R.

  公开号：US20100041821A1

  公开（公告）日：2010-02-18

  An alkyd resin comprising A) a polyol-polyacid alkyd; and B) a composition comprising a highly esterified polyol polyester, wherein the polyester comprises a polyol residue and a plurality of fatty acids esters, and wherein from about 5% to about 80% of the fatty acid esters contains exactly one pair of conjugated double bonds.
• HIGHLY ESTERIFIED POLYOL POLYESTERS WITH ONE PAIR OF CONJUGATED DOUBLE BONDS
  申请人：Berger Roger Stephen

  公开号：US20100041849A1

  公开（公告）日：2010-02-18

  A composition comprising a highly esterified polyol polyester wherein the polyester comprises a polyol residue and a plurality of fatty acids esters, and wherein from about 5% to about 80% of the fatty acid esters contains exactly one pair of conjugated double bonds.
• US5855917A
  申请人：——

  公开号：US5855917A

  公开（公告）日：1999-01-05
• [EN] METHOD FOR CONTROLLING BODY FAT AND/OR BODY WEIGHT IN ANIMALS AND PHARMACEUTICAL COMPOSITIONS FOR USE THEREIN<br/>[FR] PROCEDE PERMETTANT D'AGIR SUR LE POIDS DE LA GRAISSE CORPORELLE ET/OU SUR LE POIDS VIF CHEZ DES ANIMAUX, COMPOSITIONS A USAGE PHARMACEUTIQUES AFFERENTES
  申请人：WISCONSIN ALUMNI RESEARCH FOUNDATION

  公开号：WO1998024422A2

  公开（公告）日：1998-06-11

  (EN) Methods of inhibiting lipoprotein lipase and controlling the body fat and the body weight of an animal employ an effective amount of at least one 20 carbon, conjugated, unsaturated, fatty acid. Pharmaceutical compositions for use in the method are also disclosed.(FR) L'invention a trait à des procédés visant à inhiber la lipoprotéine lipase et permettant d'agir sur le poids de la graisse corporelle et/ou sur le poids vif chez un animal, lesquels procédés font intervenir une quantité efficace d'au moins un acide gras conjugué et insaturé, comportant 20 atomes de carbone. L'invention concerne également des compositions à usage pharmaceutique utilisées dans le cadre desdits procédés.